390 related articles for article (PubMed ID: 23811072)
1. A neuregulin 1 transmembrane domain mutation causes imbalanced glutamatergic and dopaminergic receptor expression in mice.
Newell KA; Karl T; Huang XF
Neuroscience; 2013 Sep; 248():670-80. PubMed ID: 23811072
[TBL] [Abstract][Full Text] [Related]
2. Neuregulin 1 expression and electrophysiological abnormalities in the Neuregulin 1 transmembrane domain heterozygous mutant mouse.
Long LE; Anderson P; Frank E; Shaw A; Liu S; Huang XF; Pinault D; Karl T; O'Brien TJ; Shannon Weickert C; Jones NC
PLoS One; 2015; 10(5):e0124114. PubMed ID: 25992564
[TBL] [Abstract][Full Text] [Related]
3. Perinatal phencyclidine treatment alters neuregulin 1/erbB4 expression and activation in later life.
du Bois TM; Newell KA; Huang XF
Eur Neuropsychopharmacol; 2012 May; 22(5):356-63. PubMed ID: 21962913
[TBL] [Abstract][Full Text] [Related]
4. Schizophrenia-related endophenotypes in heterozygous neuregulin-1 'knockout' mice.
O'Tuathaigh CM; Harte M; O'Leary C; O'Sullivan GJ; Blau C; Lai D; Harvey RP; Tighe O; Fagan AJ; Kerskens C; Reynolds GP; Waddington JL
Eur J Neurosci; 2010 Jan; 31(2):349-58. PubMed ID: 20074216
[TBL] [Abstract][Full Text] [Related]
5. Schizophrenia: more evidence for less glutamate.
Morrison PD; Pilowsky LS
Expert Rev Neurother; 2007 Jan; 7(1):29-31. PubMed ID: 17187494
[TBL] [Abstract][Full Text] [Related]
6. Do transmembrane domain neuregulin 1 mutant mice exhibit a reliable sensorimotor gating deficit?
Karl T; Burne TH; Van den Buuse M; Chesworth R
Behav Brain Res; 2011 Oct; 223(2):336-41. PubMed ID: 21605597
[TBL] [Abstract][Full Text] [Related]
7. Increased levels of serotonin 2A receptors and serotonin transporter in the CNS of neuregulin 1 hypomorphic/mutant mice.
Dean B; Karl T; Pavey G; Boer S; Duffy L; Scarr E
Schizophr Res; 2008 Feb; 99(1-3):341-9. PubMed ID: 18054201
[TBL] [Abstract][Full Text] [Related]
8. Reciprocal signalling between NR2 subunits of the NMDA receptor and neuregulin1 and their role in schizophrenia.
Geddes AE; Huang XF; Newell KA
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):896-904. PubMed ID: 21371516
[TBL] [Abstract][Full Text] [Related]
9. Transmembrane domain Nrg1 mutant mice show altered susceptibility to the neurobehavioural actions of repeated THC exposure in adolescence.
Long LE; Chesworth R; Huang XF; McGregor IS; Arnold JC; Karl T
Int J Neuropsychopharmacol; 2013 Feb; 16(1):163-75. PubMed ID: 22226049
[TBL] [Abstract][Full Text] [Related]
10. Antipsychotic treatment and neuregulin 1-ErbB4 signalling in schizophrenia.
Pan B; Huang XF; Deng C
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):924-30. PubMed ID: 21513767
[TBL] [Abstract][Full Text] [Related]
11. Disruption to social dyadic interactions but not emotional/anxiety-related behaviour in mice with heterozygous 'knockout' of the schizophrenia risk gene neuregulin-1.
O'Tuathaigh CM; O'Connor AM; O'Sullivan GJ; Lai D; Harvey R; Croke DT; Waddington JL
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):462-6. PubMed ID: 17980471
[TBL] [Abstract][Full Text] [Related]
12. Altered motor activity, exploration and anxiety in heterozygous neuregulin 1 mutant mice: implications for understanding schizophrenia.
Karl T; Duffy L; Scimone A; Harvey RP; Schofield PR
Genes Brain Behav; 2007 Oct; 6(7):677-87. PubMed ID: 17309661
[TBL] [Abstract][Full Text] [Related]
13. Neuregulin 1 and schizophrenia.
Stefansson H; Steinthorsdottir V; Thorgeirsson TE; Gulcher JR; Stefansson K
Ann Med; 2004; 36(1):62-71. PubMed ID: 15000348
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic characterization of spatial cognition and social behavior in mice with 'knockout' of the schizophrenia risk gene neuregulin 1.
O'Tuathaigh CM; Babovic D; O'Sullivan GJ; Clifford JJ; Tighe O; Croke DT; Harvey R; Waddington JL
Neuroscience; 2007 Jun; 147(1):18-27. PubMed ID: 17512671
[TBL] [Abstract][Full Text] [Related]
15. Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia.
Hahn CG; Wang HY; Cho DS; Talbot K; Gur RE; Berrettini WH; Bakshi K; Kamins J; Borgmann-Winter KE; Siegel SJ; Gallop RJ; Arnold SE
Nat Med; 2006 Jul; 12(7):824-8. PubMed ID: 16767099
[TBL] [Abstract][Full Text] [Related]
16. Cognition in transmembrane domain neuregulin 1 mutant mice.
Duffy L; Cappas E; Lai D; Boucher AA; Karl T
Neuroscience; 2010 Oct; 170(3):800-7. PubMed ID: 20678553
[TBL] [Abstract][Full Text] [Related]
17. Heterozygous neuregulin 1 mice display greater baseline and Delta(9)-tetrahydrocannabinol-induced c-Fos expression.
Boucher AA; Hunt GE; Karl T; Micheau J; McGregor IS; Arnold JC
Neuroscience; 2007 Nov; 149(4):861-70. PubMed ID: 17905522
[TBL] [Abstract][Full Text] [Related]
18. Biodistribution and brain permeability of the extracellular domain of neuregulin-1-β1.
Rösler TW; Depboylu C; Arias-Carrión O; Wozny W; Carlsson T; Höllerhage M; Oertel WH; Schrattenholz A; Höglinger GU
Neuropharmacology; 2011 Dec; 61(8):1413-8. PubMed ID: 21903113
[TBL] [Abstract][Full Text] [Related]
19. Neuregulin-1 mutant mice indicate motor and sensory deficits, indeed few references for schizophrenia endophenotype model.
Schneider S; Götz K; Birchmeier C; Schwegler H; Roskoden T
Behav Brain Res; 2017 Mar; 322(Pt A):177-185. PubMed ID: 28089851
[TBL] [Abstract][Full Text] [Related]
20. Decreased Neuregulin 1 C-terminal fragment in Brodmann's area 6 of patients with schizophrenia.
Barakat A; Dean B; Scarr E; Evin G
Schizophr Res; 2010 Dec; 124(1-3):200-7. PubMed ID: 20926259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
